Epilepsia, crisis convulsivas

Multiple Sclerosis (MS)

 

Epilepsia barra de fotos

 
 

Multiple Sclerosis Research

 

 

What Recent Advances Have Been Made in MS Research?

Many advances, on several fronts, have been made in the war against MS. Each advance interacts with the others, adding greater depth and meaning to each new discovery. Four areas, in particular, stand out.

Over the last decade, our knowledge about how the immune system works has grown at an amazing rate. Major gains have been made in recognizing and defining the role of this system in the development of MS lesions, giving scientists the ability to devise ways to alter the immune response. Such work is expected to yield a variety of new potential therapies that may ameliorate MS without harmful side effects.

New tools such as MRI have redefined the natural history of MS and are proving invaluable in monitoring disease activity. Scientists are now able to visualize and follow the development of MS lesions in the brain and spinal cord using MRI; this ability is a tremendous aid in the assessment of new therapies and can speed the process of evaluating new treatments.

Other tools have been developed that make the painstaking work of teasing out the disease's genetic secrets possible. Such studies have strengthened scientists' conviction that MS is a disease with many genetic components, none of which is dominant. Immune system-related genetic factors that predispose an individual to the development of MS have been identified, and may lead to new ways to treat or prevent the disease.

In fact, a treatment that may actually slow the course of the disease has been found and a growing number of therapies are now available that effectively treat some MS symptoms. In addition, there are a number of treatments under investigation that may curtail attacks or improve function of demyelinated nerve fibers. Over a dozen clinical trials testing potential therapies are under way, and additional new treatments are being devised and tested in animal models.

What Research Remains to be Done?

The role of genetic risk factors, and how they can be modified, must be more clearly defined. Environmental triggers, such as viruses or toxins, need to be investigated further. The specific cellular and subcellular targets of immune attack in the brain and spinal cord, and the subsets of T cells involved in that attack, need to be identified. Knowledge of these aspects of the disease will enable scientists to develop new methods for halting-or reversing and repairing-the destruction of myelin that causes the symptoms of MS.

What is the Outlook for People With MS?

The 1990s-proclaimed the "Decade of the Brain" in 1989 by President Bush and Congress-have seen an unparalleled explosion of knowledge about neurological disorders. New technologies are forcing even complex diseases like MS to yield up their secrets. These burgeoning opportunities in the field of neurological research have prompted the National Advisory Neurological Disorders and Stroke Council to suggest that an effective treatment for and the cause of MS may be found during the Decade of the Brain. The former has already been achieved; scientists continue to diligently search for the latter. Their dedication is the best hope for a cure, or, better yet, a way to prevent MS altogether.

How Can I Help Research?

The NINDS contributes to the support of the Human Brain and Spinal Fluid Resource Center in Los Angeles. This bank supplies investigators around the world with tissue from patients with neurological and other disorders. Tissue from individuals with MS is needed to enable scientists to study this disorder more intensely. Prospective donors may contact:

Human Brain and Spinal Fluid Resource Center
Neurology Research (127A)
W. Los Angeles Healthcare Center
11301 Wilshire Blvd. Bldg. 212
Los Angeles, CA 90073
310-268-3536
24-hour pager: 310-636-5199
Email: RMNbbank@ucla.edu
http://www.loni.ucla.edu/~nnrsb/NNRSB

National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health
Brain Resources and Information Network

¿Do you need more information on Multiple Sclerosis?

Google

 

Copyright www.elmejorguia.com 2005-2008

---------------------------------------------------------------------------------------------------------

¿Did you like this page from Elmejorguia?

Visit: Elmejorguia.com

 

Where can I get more information?
 

For more information on neurological disorders or research programs funded by the National Institute of Neurological Disorders and Stroke, contact the Institute's Brain Resources and Information Network (BRAIN) at:

BRAIN
P.O. Box 5801
Bethesda, MD 20824
(800) 352-9424
http://www.ninds.nih.gov
 

Information also is available from the following organizations:

Clearinghouse on Disability Information
Special Education & Rehabilitative Services Communications & Customer Service Team
550 12th Street, SW, Rm. 5133
Washington, DC   20202-2550
http://www.ed.gov/about/offices/list/osers
Tel: 202-245-7307 202-205-5637 (TTD)
Fax: 292024507636

 

International Essential Tremor Foundation
P.O. Box 14005
Lenexa, KS   66285-4005
http://www.essentialtremor.org
Tel: 913-341-3880 888-387-3667
Fax: 913-341-1296
Provides educational information, funds research in tremor disorders, and offers services and support to individuals diagnosed with essential tremor, their families, and health care providers. Information and support includes a quarterly newsletter, support groups, and physician information and referrals.

 

Multiple Sclerosis Association of America
706 Haddonfield Road
Cherry Hill, NJ   08002
msaa@msaa.com
http://www.msaa.com
Tel: 856-488-4500 800-532-7667
Fax: 856-661-9797
National, non-profit organization dedicated to enhancing the quality of life for those affected by multiple sclerosis. MSAA provides ongoing support and direct services to individuals with MS and their families and works to promote a greater understanding of the needs and challenges of those who face physical obstacles.

 

Multiple Sclerosis Foundation
6350 North Andrews Avenue
Ft. Lauderdale, FL   33309-2130
support@msfocus.org
http://www.msfocus.org
Tel: 954-776-6805 888-MSFOCUS (673-6287)
Fax: 954-351-0630
Dedicated to helping people with MS, the Multiple Sclerosis Foundation offers a wide array of free services including: national toll-free support, educational programs, homecare services, support groups, assistive technology programs, publications, a comprehensive website, and more programs to improve the quality of life for those affected by MS.

 

National Rehabilitation Information Center (NARIC)
4200 Forbes Boulevard
Suite 202
Lanham, MD   20706-4829
naricinfo@heitechservices.com
http://www.naric.com
Tel: 301-459-5900/301-459-5984 (TTY) 800-346-2742
Fax: 301-562-2401

 

National Ataxia Foundation (NAF)
2600 Fernbrook Lane North
Suite 119
Minneapolis, MN   55447-4752
naf@ataxia.org
http://www.ataxia.org
Tel: 763-553-0020
Fax: 763-553-0167
Encourages and supports research into the hereditary ataxias, a group of chronic and progressive neurological disorders affecting coordination. Sponsors chapters and support groups throughout the U.S.A. and Canada. Publishes a quarterly newsletter and educational literature on the various forms of ataxia.

 

National Multiple Sclerosis Society
733 Third Avenue
6th Floor
New York, NY   10017-3288
nat@nmss.org
http://www.nationalmssociety.org
Tel: 212-986-3240 800-344-4867 (FIGHTMS)
Fax: 212-986-7981
Funds research, helps families stay together, provides accurate and up-to-date information, helps with employment issues, offers free counseling, runs self-help groups, advocates for people with disabilities, and provides referrals to medical professionals.

 

American Autoimmune Related Diseases Association
22100 Gratiot Avenue
Eastpointe
East Detroit, MI   48201-2227
aarda@aarda.org
http://www.aarda.org
Tel: 586-776-3900 800-598-4668
Fax: 586-776-3903
National organization that works to alleviate suffering and the socioeconomic impact of autoimmunity. Dedicated to the eradication of autoimmune diseases through fostering and facilitating collaboration in the areas of education, research, and patient services.

 

National Organization for Rare Disorders (NORD)
P.O. Box 1968
(55 Kenosia Avenue)
Danbury, CT   06813-1968
orphan@rarediseases.org
http://www.rarediseases.org
Tel: 203-744-0100 Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291
Federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. Committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.

 

Well Spouse Association
63 West Main Street
Suite H
Freehold, NJ   07728
info@wellspouse.org
http://www.wellspouse.org
Tel: 800-838-0879 732-577-8899
Fax: 732-577-8644
International non-profit organization whose mission is to provide emotional support to, raise consciousness about, and advocate for the spouses/partners and children of the chronically ill and/or disabled.

 

Paralyzed Veterans of America (PVA)
801 18th Street, NW
Washington, DC   20006-3517
info@pva.org
http://www.pva.org
Tel: 202-USA-1300 (872-1300) 800-424-8200
Fax: 202-785-4452
Non-profit organization dedicated to serving the needs of its members—more than 21,000 veterans paralyzed by spinal cord injury or disease, as well as caregivers and others affected by these disabilities—through advocacy, education, and research programs.

 

Accelerated Cure Project for Multiple Sclerosis
300 Fifth Avenue
Waltham, MA   02451
info@acceleratedcure.org
http://www.acceleratedcure.org
Tel: 781-487-0008
Fax: 781-487-0009
National nonprofit organization dedicated to the creation and execution of a plan to cure MS by determining its causes. Developing a multi-disciplinary blood, tissue, and data bank.

 

Glossary

 

antibodies - proteins made by the immune system that bind to structures (antigens) they recognize as foreign to the body.

antigen - a structure foreign to the body, such as a virus. The body usually responds to antigens by producing antibodies.

ataxia - a condition in which the muscles fail to function in a coordinated manner.

autoimmune disease - a disease in which the body's defense system malfunctions and attacks a part of the body itself rather than foreign matter.

blood/brain barrier - a membrane that controls the passage of substances from the blood into the central nervous system.

cerebrospinal fluid - the colorless liquid, consisting partially of substances filtered from blood and partially by secretions released by brain cells, that circulates around and through the cavities of the brain and spinal cord. Physicians use a variety of tests-electrophoresis, isoelectric focusing, capillary isotachophoresis, and radioimmunoassay-to study cerebrospinal fluid for abnormalities often associated with MS.

cytokines - powerful chemical substances secreted by T cells. Cytokines are an important factor in the production of inflammation and show promise as treatments for MS.

demyelination - damage caused to myelin by recurrent attacks of inflammation. Demyelination ultimately results in nervous system scars, called plaques, which interrupt communications between the nerves and the rest of the body.

experimental allergic encephalomyelitis (EAE) - a chronic brain and spinal cord disease similar to MS which is induced by injecting myelin basic protein into laboratory animals.

fatigue - tiredness that may accompany activity or may persist even without exertion.

gadolinium - a chemical compound given during MRI scans that helps distinguish new lesions from old.

human leukocyte antigens (HLAs) - antigens, tolerated by the body, that correspond to genes that govern immune responses. Also known as

major histocompatibility complex.

immunoglobulin G (IgG) - an antibody-containing substance produced by human plasma cells in diseased central nervous system plaques. Levels of IgG are increased in the cerebrospinal fluid of most MS patients.

immunosuppression - suppression of immune system functions. Many medications under investigation for the treatment of MS are immunosuppressants.

interferons - cytokines belonging to a family of antiviral proteins that occur naturally in the body. Gamma interferon is produced by immune system cells, enhances T-cell recognition of antigens, and causes worsening of MS symptoms. Alpha and beta interferon probably exert a suppressive effect on the immune system and may be beneficial in the treatment of MS.

lesion - an abnormal change in the structure of an organ due to disease or injury.

magnetic resonance imaging (MRI) - a non-invasive scanning technique that enables investigators to see and track MS lesions as they evolve.

myelin - a fatty covering insulating nerve cell fibers in the brain and spinal cord, myelin facilitates the smooth, high-speed transmission of electrochemical messages between these components of the central nervous system and the rest of the body. In MS, myelin is damaged through a process known as demyelination, which results in distorted or blocked signals.

myelin basic protein (MBP) - a major component of myelin. When myelin breakdown occurs (as in MS), MBP can often be found in abnormally high levels in the patient's cerebrospinal fluid. When injected into laboratory animals, MBP induces experimental allergic encephalomyelitis, a chronic brain and spinal cord disease similar to MS.

oligodendrocytes - cells that make and maintain myelin.

optic neuritis - an inflammatory disorder of the optic nerve that usually occurs in only one eye and causes visual loss and sometimes blindness. It is generally temporary.

paresthesias - abnormal sensations such as numbness, prickling, or "pins and needles."

plaques - patchy areas of inflammation and demyelination typical of MS, plaques disrupt or block nerve signals that would normally pass through the regions affected by the plaques.

receptor - a protein on a cell's surface that allows the cell to identify antigens.

retrobulbar neuritis - an inflammatory disorder of the optic nerve that is usually temporary. It causes rapid loss of vision and may cause pain upon moving the eye.

spasticity - involuntary muscle contractions leading to spasms and stiffness or rigidity. In MS, this condition primarily affects the lower limbs.

T cells - immune system cells that develop in the thymus gland. Findings suggest that T cells are implicated in myelin destruction.

transverse myelitis - an acute spinal cord disorder causing sudden low back pain and muscle weakness and abnormal sensory sensations in the lower extremities. Transverse myelitis often remits spontaneously; however, severe or long-lasting cases may lead to permanent disability.

white matter - nerve fibers that are the site of MS lesions and underlie the gray matter of the brain and spinal cord.

 

 

"Multiple Sclerosis: Hope Through Research," NINDS. Publication date September 1996.

NIH Publication No. 96-75